Enhanced Synergistic Antibacterial and Antibiofilm Efficacy of Main-Chain Polysulfoniums with Antibiotics by Balancing Charge Density and Amphiphilicity

Infection diseases caused by Gram-negative pathogens are exceedingly difficult to treat because their characteristic outer membrane limits antibiotic entry. Herein, we report the development of main-chain polysulfoniums with different charge densities and amphiphilicities based on the quantitative m...

Full description

Saved in:
Bibliographic Details
Published inACS applied polymer materials Vol. 5; no. 6; pp. 4437 - 4447
Main Authors Zhao, Yao, Wang, Xiao, Hu, Yongjin, Zhao, Jinghua, Sun, Mei, Yang, Mingdi, Xuan, Han, Wang, Xianbiao, Zhang, Jingyan, Zhu, Zhiyuan, Rao, Jingyi
Format Journal Article
LanguageEnglish
Published American Chemical Society 09.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Infection diseases caused by Gram-negative pathogens are exceedingly difficult to treat because their characteristic outer membrane limits antibiotic entry. Herein, we report the development of main-chain polysulfoniums with different charge densities and amphiphilicities based on the quantitative methylation reaction. By regulating the membrane-disruption capability, the combined efficacy of polysulfoniums and antibiotic rifampicin can be manipulated from no interaction to synergy against Gram-negative bacteria Escherichia coli. After incubating with synergistic polysulfoniums/rifampicin combinations at a minimum inhibitory concentration (MIC), the time needed to achieve a 6-log reduction of E. coli can be accelerated 8 times compared to the antibiotic treatment. At 1/2 MIC, polysulfoniums/rifampicin combinations can provide a 90% reduction in biofilm mass and 8-log orders of embedded bacteria killing in 3-day-mature E. coli biofilms. This work demonstrates that alkylation chemistry can serve as a reliable means to create antibiotic adjuvants in combating infections caused by Gram-negative pathogens and biofilms.
ISSN:2637-6105
2637-6105
DOI:10.1021/acsapm.3c00572